NASDAQ Composite Index

NASDAQ Composite Index handeln
25.944,69 PKT -95,35 PKT -0,37 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 969427

ISIN XC0009694271


Analysen zu NASDAQ Composite Index-Werten

Datum Rating Analyst
21.05.12 Salesforce overweight Barclays Capital
21.05.12 Intuit overweight Barclays Capital
21.05.12 Intuit kaufen Die Actien-Börse
21.05.12 Visa outperform RBC Capital Markets
21.05.12 Salesforce outperform RBC Capital Markets
21.05.12 Applied Materials outperform RBC Capital Markets
21.05.12 NetApp outperform RBC Capital Markets
21.05.12 OraSure Technologies outperform Barrington Research
21.05.12 Ross Stores sector perform RBC Capital Markets
21.05.12 Autodesk sector perform RBC Capital Markets
21.05.12 Anglo American sector perform RBC Capital Markets
18.05.12 Hub Group buy Stifel, Nicolaus & Co., Inc.
18.05.12 Applied Materials buy Stifel, Nicolaus & Co., Inc.
18.05.12 Salesforce buy UBS AG
17.05.12 Salesforce outperform RBC Capital Markets
17.05.12 Teva Pharmaceutical Industries outperform RBC Capital Markets
16.05.12 Apple overweight Barclays Capital
16.05.12 J.B. Hunt Transportation Services outperform William Blair
16.05.12 Ultra Clean hold Needham & Company, LLC
15.05.12 Applied Materials hold Needham & Company, LLC
15.05.12 Amedisys neutral Robert W. Baird & Co. Incorporated
15.05.12 NVIDIA equal-weight Barclays Capital
15.05.12 OraSure Technologies buy Barrington Research
11.05.12 Apple overweight Morgan Stanley
11.05.12 Intel buy UBS AG
11.05.12 Amazon halten Der Aktionär
10.05.12 Teva Pharmaceutical Industries buy UBS AG
10.05.12 Teva Pharmaceutical Industries hold Needham & Company, LLC
10.05.12 Regeneron Pharmaceuticals outperform RBC Capital Markets
10.05.12 Intel outperform RBC Capital Markets
10.05.12 Alexion Pharmaceuticals overweight Barclays Capital
10.05.12 Biogen buy UBS AG
10.05.12 Ceragon Networks outperform RBC Capital Markets
09.05.12 NuVasive overweight Barclays Capital
09.05.12 Deckers Outdoor overweight Barclays Capital
09.05.12 Bed Bath Beyond overweight Barclays Capital
09.05.12 Apple overweight Barclays Capital
09.05.12 Wynn Resorts overweight Barclays Capital
09.05.12 Vertex Pharmaceuticals overweight Barclays Capital
08.05.12 Wynn Resorts buy UBS AG